A detailed history of Hantz Financial Services, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 33,367 shares of BSX stock, worth $3.01 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
33,367
Previous 33,104 0.79%
Holding current value
$3.01 Million
Previous $2.55 Million 9.69%
% of portfolio
0.05%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $19,188 - $22,092
263 Added 0.79%
33,367 $2.8 Million
Q2 2024

Jul 30, 2024

BUY
$67.33 - $77.71 $2.23 Million - $2.57 Million
33,104 New
33,104 $2.55 Million
Q1 2024

Aug 06, 2024

BUY
$57.6 - $68.62 $11,808 - $14,067
205 Added 0.62%
33,039 $2.26 Million
Q4 2023

Aug 06, 2024

BUY
$48.64 - $57.81 $41,052 - $48,791
844 Added 2.64%
32,834 $1.9 Million
Q3 2023

Aug 06, 2024

BUY
$50.19 - $54.68 $1.36 Million - $1.48 Million
27,026 Added 544.44%
31,990 $1.69 Million
Q4 2022

Aug 06, 2024

BUY
$39.56 - $47.22 $166,587 - $198,843
4,211 Added 559.23%
4,964 $230,000
Q2 2022

Aug 06, 2024

SELL
$35.24 - $47.1 $704 - $942
-20 Reduced 2.59%
753 $28,000
Q1 2022

Aug 06, 2024

SELL
$40.9 - $45.1 $2.29 Million - $2.53 Million
-56,040 Reduced 98.64%
773 $34,000
Q4 2021

Aug 06, 2024

BUY
$38.07 - $44.87 $142,686 - $168,172
3,748 Added 7.06%
56,813 $2.41 Million
Q3 2021

Aug 06, 2024

BUY
$41.23 - $45.88 $321,923 - $358,231
7,808 Added 17.25%
53,065 $2.3 Million
Q2 2021

Aug 06, 2024

BUY
$38.58 - $44.24 $41,820 - $47,956
1,084 Added 2.45%
45,257 $1.94 Million
Q1 2021

Aug 06, 2024

BUY
$35.27 - $39.67 $390,403 - $439,107
11,069 Added 33.44%
44,173 $1.71 Million
Q4 2020

Aug 06, 2024

BUY
$33.15 - $41.97 $353,412 - $447,442
10,661 Added 32.2%
43,765 $1.57 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.